- Home
- RSSS vs TIL Comparison
RSSS vs TIL Comparison
Compare RSSS & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- TIL
- Stock Information
- Founded
- RSSS 2006
- TIL 2018
- Country
- RSSS United States
- TIL United States
- Employees
- RSSS N/A
- TIL N/A
- Industry
- RSSS Business Services
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- RSSS Consumer Discretionary
- TIL Health Care
- Exchange
- RSSS Nasdaq
- TIL Nasdaq
- Market Cap
- RSSS 110.0M
- TIL 177.1M
- IPO Year
- RSSS N/A
- TIL 2021
- Fundamental
- Price
- RSSS $3.26
- TIL $18.94
- Analyst Decision
- RSSS Strong Buy
- TIL Strong Buy
- Analyst Count
- RSSS 1
- TIL 5
- Target Price
- RSSS $5.00
- TIL $100.67
- AVG Volume (30 Days)
- RSSS 76.2K
- TIL 109.9K
- Earning Date
- RSSS 11-13-2025
- TIL 11-12-2025
- Dividend Yield
- RSSS N/A
- TIL N/A
- EPS Growth
- RSSS N/A
- TIL N/A
- EPS
- RSSS 0.04
- TIL N/A
- Revenue
- RSSS $49,057,981.00
- TIL N/A
- Revenue This Year
- RSSS $5.79
- TIL N/A
- Revenue Next Year
- RSSS $8.46
- TIL N/A
- P/E Ratio
- RSSS $80.75
- TIL N/A
- Revenue Growth
- RSSS 9.94
- TIL N/A
- 52 Week Low
- RSSS $2.32
- TIL $10.80
- 52 Week High
- RSSS $4.24
- TIL $44.50
- Technical
- Relative Strength Index (RSI)
- RSSS 43.92
- TIL 45.86
- Support Level
- RSSS $3.19
- TIL $18.10
- Resistance Level
- RSSS $3.54
- TIL $20.32
- Average True Range (ATR)
- RSSS 0.15
- TIL 1.56
- MACD
- RSSS -0.04
- TIL 0.20
- Stochastic Oscillator
- RSSS 22.38
- TIL 37.96
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.